NICOLE SPORRER: Open Payments
NPI 1942821244 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 75 payments from 20 companies in 2025. Trend: 2023 $1,023 · 2024 $1,101 · 2025 $1,135
Food & beverage: $1,135
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 24 | $220 |
| ABBVIE INC. | 16 | $194 |
| AstraZeneca Pharmaceuticals LP | 5 | $156 |
| Novo Nordisk Inc | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| Esperion Therapeutics, Inc. | 2 | $44 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $38 |
| Amgen Inc. | 2 | $35 |
Products named: FARXIGA, VRAYLAR, NURTEC ODT, QULIPTA, CAPLYTA, VOQUEZNA, JARDIANCE, ZAVZPRET.
Industry payments across IA — which companies pay providers there.
